Intracellular-Localization and Processing of Pp60v-Src Proteins Expressed by 2 Distinct Temperature-Sensitive Mutants of Rous-Sarcoma Virus by Stoker, Andrew W. et al.
Vol. 58, No. 3JOURNAL OF VIROLOGY, June 1986, p. 876-883
0022-538X/86/060876-08$02.00/0
Copyright C 1986, American Society for Microbiology
Intracellular Localization and Processing of pp6Ov-src Proteins
Expressed by Two Distinct Temperature-Sensitive Mutants of
Rous Sarcoma Virus
ANDREW W. STOKER,* STUART KELLIE, AND JOHN A. WYKE
Imperial Cancer Research Fund Laboratories, St. Bartholomew's Hospital, Dominion House, London ECIA 7BE,
United Kingdom
Received 9 December 1985/Accepted 17 February 1986
The transforming protein of Rous sarcoma virus, pp6Ov-src, is known to be a tyrosine protein kinase, but the
mechanism of cell transformation remains unclear. In further investigating pp6ovsrc structure and function, we
have analyzed two temperature-sensitive (ts) Rous sarcoma virus src gene mutants, tsLA29 and tsLA32. The
mutations in tsLA29 and tsLA32 map in the carboxy-terminal region and the amino-terminal half of pp6O-s'c,
respectively, and encode mutant proteins with either temperature-labile (tsLA29) or -stable (tsLA32) kinase
activities. Here we examined the intracellular processing and localization of these pp6o-src mutants and
extended our characterization of transformation parameters expressed by cells infected by the Rous sarcoma
virus variants. No obvious defects in functional integrity of the tsLA32 pp6o-src could yet be demonstrated,
whereas the tsLA29 pp6Ovsrc was perturbed not only in kinase activity, but also in aspects of protein processing
and localization. Analysis of transformation parameters expressed by infected cells demonstrated the complete
temperature lability of both mutants.
The v-src gene of Rous sarcoma virus (RSV) encodes a
phosphoprotein of molecular weight 60,000, pp60v-src, which
can induce in vitro neoplastic transformation of a variety of
cells (24, 38). This transformation is a complex process,
involving considerable structural and metabolic perturba-
tions to the cell, and yet pp6Ov-src is capable of initiating and
maintaining the pleiotropic changes which are seen (18). The
mechanisms by which pp6Ov-src induces transformation re-
main unclear, although a considerable amount of knowledge
has been gained in recent years concerning its structure,
location, and functional activity within the cell.
The only well-defined function ascribed to pp6Ov-src is that
of a tyrosine protein kinase (2, 6, 7, 16, 25, 30, 31, 42), for
which a number of putative target proteins have been
identified in the cell (1, 8, 34). These include two
phosphoproteins, pp36 (15, 39) and pp5O (23), vinculin (41),
and three glycolytic enzymes (10). However, in no case has
specific phosphorylation of these substrates been shown to
be necessary for transformation, suggesting that the critical
cellular targets have yet to be identified.
An additional property of the pp6Ov-src protein is its
association with the plasma membrane, where the majority
of mature pp60v-src is found (for review, see reference 27).
The importance of this localization is demonstrated by
mutants showing defects in membrane binding that are also
invariably defective in some or all aspects of cell transfor-
mation (11, 20, 28). The mechanism by which pp6vsrc
associates with the membrane is unclear, but several factors
appear to be of importance in governing the transport to or
association with this site. First, the lipid myristic acid is
found covalently attached to the N-terminal glycine residue
of pp60v-src (5, 43). Absence of this lipid prevents stable
association with the membrane, thus preventing transforma-
tion, but not apparently affecting the kinase activity (13, 21,
26). The N-terminal 8 kilodaltons of pp6Ov-src is believed to
be involved in close contact with the membrane (28) and
* Corresponding author.
together with myristic acid may mediate the stable associa-
tion. In addition to these factors, pp60v-src is known to form
a transient complex with two cellular proteins, ppSO and
pp9O, soon after its synthesis on cytosolic polyribosomes (2,
4, 36). The precise role of the complex is unclear, but some
involvement in transport of pp60v-src to the membrane has
been suggested (11).
It has become clear that the functions ascribed to pp60v-src
can be crudely mapped to domains of the protein (17, 29, 37,
44). The kinase function is believed to lie in the carboxy-
terminal (C-terminal) half of the protein in an area with
sequence homology to other known tyrosine kinases (40).
The membrane binding is ascribed to the amino-terminal
(N-terminal) region, and additional areas of the protein may
provide specific binding points for the pp50-pp9O pro-
teins (46). To dissect further the structure and functions of
pp60v-src, we have been studying temperature-sensitive (ts)
mutants of the v-src gene in which different domains of the
pp60v-src protein have been perturbed. We have focused on
two mutants, tsLA32 and tsLA29, and our previous work has
shown that these mutants have lesions which either do affect
(LA29) or do not directly affect (LA32) the kinase activity of
the protein (44). The LA32 mutant is of particular interest as
it maintains elevated cellular phosphotyrosine levels and
phosphorylates pp36 (44) and vinculin (S. Kellie, B. Patel,
N. M. Wigglesworth, D. R. Critchley, and J. A. Wyke, Exp.
Cell Res., in press) at restrictive temperature, suggesting
that this mutant has a lesion in a novel domain necessary for
the maintenance of transformation.
Our work did not indicate whether the lesion in LA32 was
affecting aspects of pp60v-src localization or maturation, or
whether the LA29 pp6Ov-src exhibited defects other than in
the kinase function. To investigate these questions, we have
studied both the intracellular processing and the localization
of the mutant pp6Ov-src proteins. We show that the LA32
pp6Ov-src mutant is not significantly defective in the above
parameters and contrast these findings with those of the
LA29 mutant. In addition, having previously demonstrated
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EFFECTS OF DISTINCT ts MUTATIONS ON pp60v-src FUNCTION
the elevation of phosphotyrosine levels and the residual
soft-agar growth capacity of LA32-infected chicken embryo
fibroblasts (CEF) at 41°C (44), we were interested in exam-
ining whether additional parameters of transformation were
expressed under restrictive conditions. We describe a de-
tailed study of the dissolution of actin- and a-actinin-
containing cables and the fibronectin matrix in the mutant-
infected cells and demonstrate the full temperature lability of
these transformation parameters.
MATERIALS AND METHODS
Cells and viruses. CEF were prepared from fertile eggs of
a white leghorn and brown leghorn cross (Wickham
Laboratories, Wickham, Hampshire, U.K.). Methods of cell
culture and infection were as described previously (47).
Isolation of viruses and initial characterization have been
described before (17, 44, 49).
Antibodies and fluorescent reagents. Normal rabbit serum
was collected as described previously (44). Anti-pp6Ovsrc
antibodies were kindly provided by the following people:
JB327 monoclonal (J. Brugge [32]); anti-v-src-C (S. J.
Courtneidge); anti-src rabbit serum raised against pp60-src
expressed and purified from Escherichia coli (R. L. Erikson
[22]). Rabbit anti-mouse serum MH1 was kindly supplied by
M. Hayman. Antisera against chicken gizzard oa-actinin were
raised in rabbits and affinity purified as described previously
(26a). Fluorescein isothiocyanate-conjugated affinity-
purified goat anti-rabbit and goat anti-mouse immunoglob-
ulins were obtained from Sigma Ltd. Nitrobenzo-oxadiazole
(NBD)-phallicidin was obtained from Molecular Probes Inc.,
Junction City, Ore., and was used as described by the
supplier.
Immunoprecipitation and gel electrophoresis. Cell lysis,
immunoprecipitations, and sodium dodecyl sulfate-
polyacrylamide slab gel electrophoresis were performed as
described previously (44). The lysis buffers used were as
follows: modified RIPA buffer (10 mM Tris hydrochloride,
pH 7.2, 150 mM NaCl, 1% deoxycholate, 1% Triton X-100,
0.1% sodium dodecyl sulfate, 0.1 trypsin inhibitor unit per
ml of aprotinin [Sigma], 20 mM NaPP1; buffer A (150 mM
NaCl, 10 mM Tris hydrochloride, pH 7.0, 1% Nonidet P-40,
20 mM NaPPi).
Immunofluorescence. Cells were grown on 13-mm-
diameter cover slips for at least 18 h and fixed in 3.8%
formaldehyde in phosphate-buffered saline (PBS) for 30 min
followed by extensive washing in PBS. After permeabiliza-
tion by immersion in PBS containing 1% Nonidet P-40, the
cover slips were washed and overlaid with 50 ,I of the first
antibody in PBS (anti-a-actinin, 50 ,ug/ml; antifibronectin,
1:100 dilution; JB327 anti-pp60vsrc, 1:20 dilution) for 30 min.
After thorough washing, the cover slips were overlaid with
50 RI of a 1:20 dilution of fluorescein isothiocyanate-
conjugated goat anti-rabbit or goat anti-mouse immunoglob-
ulin for 30 min. Cover slips were washed and mounted in
PBS-glycerol (1:9) containing 1 mg of p-phenylamine
diamine per ml to reduce photobleaching and viewed with a
Leitz Dialux microscope equipped with epifluorescence.
Photomicrographs were taken with Ilford HP5 film.
Cell fractionation. Plates (35 mm) of RSV-infected CEF
were incubated for 30 min in methionine-free medium and
then labeled for 1 h with 200 ,uCi of [35S]methionine per ml at
35 and 41°C. The label was removed and chased in cold,
complete medium for 2 h at the respective temperatures.
Uninfected CEF carrier cells (107) were suspended and
washed twice in PBS. The labeled cells were rinsed twice
with PBS, scraped into the carrier cell suspension with a
rubber policeman, and washed once with PBS. The cells
were resuspended in 3 ml of hypotonic buffer (10 mM Tris
hydrochloride, pH 7, 1 mM MgCl2) and left to swell on ice
for 4 min. NaPP1 to 10 mM and 2 trypsin inhibitor units of
Aprotinin (Sigma) were added, and the cells were lysed with
30 strokes of a tight-fitting Dounce homogenizer. The lysates
were cleared of unbroken cells and nuclei with a low-speed
spin (600 x g) for 10 min. Half of the resultant supernatant
was not further treated (fraction MC), and the other half was
further spun at 80,000 x g for 30 min to obtain a crude
membrane pellet (fraction M) and a supernatant of soluble
cytoplasmic constituents (fraction C). All fractions were
adjusted to RIPA concentration and immunoprecipitated
with normal rabbit serum and the anti-v-src-C antisera. This
procedure provided 90 to 100% recovery of pp6Ov-src in the M
and C fractions when compared with the total unfractionated
MC sample. Immunoprecipitates were subjected to poly-
acrylamide gel electrophoresis, and the gels were impreg-
nated with Amplify (Amersham International) and
fluorographed with Kodak XAR-5 film. pp6Ov-src in each
fraction was quantified by scanning densitometry of the
resulting fluorographs, using a Joyce-Loebl densitometer.
pp6&Vsrc complex analysis. (i) Complex immunoprecipita-
tion. CEF infected with RSV were labeled for 18 h with 100
,uCi of [35S]methionine per ml in complete medium. Cells
were washed twice with PBS and lysed in buffer A. The
lysates were normalized for protein content and halves were
immunoprecipitated with normal rabbit serum and monoclo-
nal JB237, followed by rabbit anti-mouse serum MH1.
Immunoprecipitates were subjected to gel electrophoresis on
10% acrylamide gels.
(ii) Complex stability analysis. Cells were labeled as above
but using 200 ,uCi of [35S]methionine per ml. Cells were
washed twice in PBS and lysed in buffer A. Immunoprecip-
itation of pp6Ov-src was performed initially as in (i) above.
Immune complexes were washed once with buffer A, and
then each sample was split into two aliquots. Each aliquot
was washed three times in either buffer A or RIPA buffer.
The immune complexes were subjected to polyacrylamide
gel electrophoresis, and after fluorography gel slices contain-
ing pp60v-src and pp9O were cut out and the 35S counts per
minute were quantitated in an LKB RackBeta scintillation
counter. Counts were corrected for background counts per
minute from control areas of the gel.
Myristic acid labeling. 9,10-[3H]myristic acid (2 mCi/ml;
Amersham International) supplied in toluene was dried and
suspended in calf serum. CEF either infected with RSV or
uninfected were labeled for 18 h with 40 ,uCi of [3H]myristic
acid per ml in complete medium at 35 and 41°C. Cells were
lysed in RIPA buffer, and pp60V-src was immune precipitated
with anti-src serum. After polyacrylamide gel electrophore-
sis, gels were impregnated with Amplify (Amersham Inter-
national) and fluorographed with Kodak XAR-5 film for 28
days. pp60v src bands were scanned with a Joyce-Loebl
densitometer, and values were normalized for the respective
lysate protein concentration.
RESULTS
pp6O-src localization: cell fractionation and immunofluores-
cence. After synthesis on cytosolic polyribosomes, and a
short lag period of 10 to 15 min, wild-type pp60v-src can be
found localized in the plasma membrane compartment of the
cell (29). It is believed that the membrane-bound form of
pp6Ov-src is the functional form of the protein, and thus it was
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of importance to determine the localization of the mutant
proteins. For this, a pulse-chase labeling protocol was used,
followed by cellular fractionation and immunoprecipitation
of pp6Ov-sc. Given the kinetics of wild-type pp6Ov-src associ-
ation with the plasma membrane, the majority of the labeled
pp64?v-src proteins will be chased to their final intracellular
location within the 2-h chase period.
Cellular fractionation of wild-type pp6Ovsrc reveals that
80% of the labeled protein is found in the crude membrane
fraction at both 35 and 41°C (Table 1). The mutant protein
encoded by LA32 behaves very similarly to the wild type at
permissive temperature, with comparable levels of pp6Ov-src
in the membrane fraction. At nonpermissive temperature
nearly 50% of the labeled pp60-src is still found in the
membrane fraction. A different pattern is found with mutant
LA29. At permissive temperature only 50% of the labeled
pp6Ov-src is found in the membrane, but this represents a
level which is clearly sufficient for cell transformation. At
nonpermissive temperature only 15% of the pp6Ov-src re-
mains in the membrane, with 85% as a cytosolic form.
We have not ruled out the possibility that the mutant
proteins, particularly that of LA29, exhibit some instability
in membrane binding during the fractionation procedure.
Thus, to confirm the membrane association pattern, and in
particular to demonstrate the association with plasma mem-
branes, we analyzed pp6ov-src localization, using indirect
immunofluorescence. Both LA29- and LA32-infected CEF
display prominent plasma membrane staining of pp6Ov-src at
permissive temperature, similar in pattern to wild-type-
transformed cells (Fig. 1). At nonpermissive temperature the
pattern of fluorescence is quite different with LA29, the
pp60v-src distribution now being of a diffuse, cytoplasmic
nature, correlating well with our cell fractionation data. In
contrast to LA29, and again in agreement with the fraction-
ation data, CEF infected with LA32 maintain staining in the
plasma membrane at 41°C, with prominent signals at cell-cell
boundaries. Although not quantitative, the membrane stain-
ing of LA32-infected CEF is reduced to some degree at
restrictive versus permissive temperature, and this may in
part be due to the flatter nature of the cells and thus the
greater spreading of the plasma membrane. Membrane stain-
ing in wild-type RSV-transformed CEF is unaffected by
growth temperature.
Association of mutant pp60vsrc proteins with the pp9O-ppSO
complex. Soon after synthesis pp6Ov-src enters a cytoplasmic
complex with cell proteins pp90 and pp50. Only a small
percentage of the total cellular pp9O is incorporated in the
complex, and newly synthesized pp9O enters a large cyto-
TABLE 1. Localization of pp6O-vsrC by cell fractionation
% of pp6VS-C at given
Cell growth tempbInfecting virus fraction' 35"C 410C
Wild-type M 82 80
PrC C 18 20
ts LA29 M 50 15
C 50 85
ts LA32 M 78 46
C 22 54
a M, Crude membrane fraction; C, cytoplasmic fraction.b Each number represents the proportion of labeled pp60.-sr in each
fraction as a percentage of the total M plus C densitometric value and is the
average of two independent experiments.
solic pool rather than the complex (4). Because of this, a long
[35S]methionine labeling period was performed to obtain the
complex with high levels of labeled pp90 associated with
pp60v-src for quantitation purposes. RSV-infected CEF were
labeled for 18 h with [35S]methionine, and pp6Ov-src was
immunoprecipitated with the monoclonal JB327 which effi-
ciently precipitates the complexed form of pp6Ov-src (32). By
this procedure, the efficiency of complex formation was
judged from the ratio of pp9O/pp60. The pp5O was not
quantitated because of the difficulty of distinguishing this
protein from pp6Ov-src breakdown products and background
proteins of a similar molecular weight.
The data in Fig. 2 demonstrate that the levels of pp9O
coprecipitated with mutant pp6Ov-src proteins were not
greatly affected by growth temperature, and the levels seen
were similar to those found with our wild-type pp6Ov-src
(quantitation of 35S counts per minute from pp60 and pp90
gel areas was confirmatory; data not shown). We did note a
small decrease in the amount of pp9O coprecipitated at 35°C
in all cases, the largest decrease was seen with the wild type,
but the significance of this is unclear. The sensitivity of
pp9O-pp60 binding to variations in detergent conditions is
shown by the following ratios of pp90 remaining bound to
pp60v-src in buffer A/RIPA: with wild-type PrC as the infect-
ing virus, 2.1; with tsLA29, 9.7; and with tsLA32, 3.3. The
pp6Ov-src proteins encoded by both mutants and wild type
bind pp90 to similar degrees in Nonidet P-40-containing
buffer, buffer A. However, in the more denaturing RIPA
buffer, containing the ionic detergent sodium dodecyl sul-
fate, a three to fourfold greater instability in pp60-pp9O
binding is found with LA29 than with LA32 or wild-type PrC.
This in vitro instability is not dependent upon the growth
temperature of the infected CEF from with the pp6Ov-src
proteins are isolated (data not shown). Under physiological
conditions, however, such an instability may well be differ-
entially expressed at 35 or 41°C and could have a significant
effect upon pp6ov-src processing and function. We are pres-
ently investigating the in vivo kinetics of complex associa-
tion with these mutants in an attempt to answer this ques-
tion.
Myristylation of pp6O-v'. The lipid myristic acid is cova-
lently attached to the N-terminal glycine residue of the
pp60v-src protein, and this modification to pp6Ov-src has been
shown to be essential for transforming activity. Given the
importance of myristic acid attachment during pp6Ov-src
maturation, it was of interest to determine whether temper-
ature shift significantly affected the myristylation states of
the ts mutant pp6Ov-src proteins.
CEF infected with the mutant viruses were labeled for 18
h with [3H]myristic acid (providing steady-state levels of
incorporation; data not shown), and pp6Ov src was im-
munoprecipitated from whole-cell lysates. The peak areas of
labeled pp6Ov-src were quantitated as described in Materials
and Methods. The incorporation of labeled myristic acid into
wild-type pp6Ov-src shows little change between the two
growth temperatures (35°C/41°C ratio = 1.5). The mutant
pp6Ov-src proteins were found to behave in a manner similar
to the wild-type protein with respect to myristic acid incor-
poration (35°C/41°C ratios: LA32, 1.5; LA29, 1.7). Buss et al.
(5) recently reported similar findings with the LA29 mutant,
but with a shorter 2-h labeling period and using [3H]palmitic
acid.
It is clear from these data that the ts lesions in both
mutants do not greatly affect the ability to incorporate
myristic acid into the mutant pp60v-src proteins and that a
defect in myristylation, which is an early step in pp6O -src
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PrC
LA29
350C
LA32
350C
CEF
LA29
41 °C
LA32
41°C
FIG. 1. Immunofluorescence localization of pp60v-src in transformed CEF. Cells were stained with monoclonal anti-pp60src as described
in Materials and Methods. (a) PrC transformed; (b) untransformed CEF; (c) LA29-transformed CEF at 35°C; (d) LA29-transformed CEF at
41°C; (f) LA32-transformed CEF at 35°C; (g) LA32-transformed CEF at 41°C. Bar = 10 ,um.
maturation (5, 19), is not responsible for their temperature
lability.
Fibronectin matrix production. The production of a fibro-
nectin matrix is dramatically reduced in CEF transformed by
RSV (35). When CEF infected with either LA29 or LA32
were grown at nonpermissive temperature, the cells pro-
duced a fibronectin matrix indistinguishable from that syn-
thesized by uninfected CEF (Fig. 3i and k). At permissive
temperature, the mutant virus-infected cells showed a large
reduction in matrix production as expected. However, al-
though the LA29-transformed CEF matrix was reduced to
the residual level seen in wild-type-transformed cells, the
LA32-transformed cells consistently produced a residual
fibronectin matrix to a greater degree than either wild-type-
or LA29-transformed cells (Fig. 3j and 1). This residual level
of fibronectin has not been analyzed quantitatively.
F-actin and a-actinin distribution. The two cytoskeletal
proteins actin and a-actinin undergo gross intracellular re-
distributions upon cell transformation by RSV (14, 33). The
temperature-dependent effects of the mutant RSV upon
these proteins were examined. The distribution of F-actin in
RSV-infected CEF was examined by fluorescence micros-
copy, using NBD-phallicidin. At 41°C both LA29- and LA32-
infected cells grew as morphologically normal, flat cells with
many prominent microfilament bundles running through the
cytoplasm similar to those seen in uninfected CEF (Fig. 3a
and c). At permissive temperature both mutants induced the
expected dissolution of actin cables in the transformed cells.
However, in the LA32-infected cells a sparse pattern of
cables was consistently seen compared with LA29- or wild-
type-transformed CEF (Fig. 3b and d). Although this obser-
vation is not quantitative, it may be related to the more
fusiform morphology of the LA32-transformed cells at 35°C
(44). The mutant- and wild-type-transformed cells all exhib-
ited characteristic aggregates of F-actin within the cytoplasm
at permissive temperature.
The distribution of a-actinin in the infected CEF closely
paralleled that of F-actin. Upon temperature shift from 35 to
41°C, the diffuse, cytoplasmic pattern of a-actinin staining
changed to the characteristic periodic staining along micro-
filament bundles as seen in uninfected CEF (Fig. 3e to h).
The mutant-infected CEF thus exhibit full temperature sen-
sitivity in the redistributions of F-actin and a-actinin,
whereas the distributions of these proteins in uninfected or
wild-type-transformed CEF were unaffected by growth tem-
perature.
DISCUSSION
In this paper we extend our characterization of the mutant
pp60v-src proteins encoded by tsLA32 and tsLA29 and ana-
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wtPrC tsLA29
35 41 35 41
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FIG. 2. Immunoprecipitation of pp6C
plex proteins. RSV-infected CEF were la
for 18 h at permissive (35°C) and nonp
tures. pp60v-src was immunoprecipitated
Lanes a, JB327 immunoprecipitates; lant
serum immunoprecipitates.
lyze further parameters of transfc
infected by these mutant RSV. TE
current knowledge of the two mutar
The mutations in LA32 and LA"
tsLA 32 mately located by marker rescue mapping: LA32 contains a
mutation(s) in the N-terminal 60% of pp6Ov-src, whereas
35 41 LA29 is mutated very near to the carboxy terminus of the
_
w protein (17).
tsLA29. Although we can detect no temperature sensitivity
in either steady-state complex levels or myristylation of this
mutant protein, it is clear that its intracellular localization is
-
_
~PP90 abnormal, particularly at restrictive temperature. A reduc-
tion in membrane binding is seen at both temperatures,
-pp60src although at 35°C there is no apparent impairment of trans-
-I;;_m formation. Although at 41°C the majority of the pp6OV-src is
cytosolic, we note that the amount of pp9O bound does not
increase proportionately, in contrast to other ts mutants of
pp60v-src, such as NY68 (11). In addition, we can detect an
increased sensitivity of pp9O-pp6O complexing to ionic de-
a b a b tergents in vitro. We suggest, given that the LA29 mutationlies outside the membrane-binding region of pp6Ovsrc, that a
-src and associated com- defect in complex binding in the cell may be one aspect of
tbeled with [35S]methionine this protein's dysfunction. This would appear to occur afteriermissive (41°C) tempera- initial complex binding, and possibly after myristylation, and
with monoclonal JB327. p
s b, control normal rabbit may lead to premature dissolution of the complex. Such a
malfunction could result in the observed failure of pp6Ov-src
to associate well with the membrane at 41°C and, bearing in
mind evidence that the C-terminal region of pp6Ov-src is
)rmation seen in CEF involved with complex binding (46), it would not be unex-
able 2 summarizes our pected. In addition, Wilkerson et al. recently described
its in this study. site-directed variants of pp6Ov-src with alterations in the
29 have been approxi- C-terminal domain of the protein (48). These proteins behave
LA 32
1. 350 350
At
FIG. 3. Staining of actin (upper panel), a-actinin (middle panel), and fibronectin (lower panel) in transformed CEF. Cells were stained with
NBD-phallicidin, rabbit anti-a-actinin, or rabbit anti-fibronectin as described in Materials and Methods. (a, e, i) LA29-transformed CEF at
41°C; (b, f, j) LA29-transformed CEF at 35°C; (c, g, k) LA32-transformed CEF at 41°C; (d, h, 1) LA32-transformed CEF at 35°C. For (a) to
(d) and (e) to (h), bar = 10 ,um. For (i) to (1), bar = 100 ,um.
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TABLE 2. Parameters of transformation and pp60v-src function in
ts mutant-infected CEF'
Infecting virus
Parameter Wild-type tsLA29 tsLA32
Transformation
Morphological transformation +b tSb ts
Soft-agar growth + ts tSC
Fibronectin matrix production + ts ts
Actin/a-actinin cable dissolu- + ts ts
tion
Hexose uptaked + ts ts
pp6fv-src function
In vitro kinase activity + ts +
In vivo phosphotyrosine ele- + ts +
vation
In vivo autophosphorylation + ts ts
36K phosphorylation + ts +
Vinculin phosphorylatione + ts +
Complex formation + +f +
Myristylation state + + +
Localizationg + ts +
a Data are presented in this paper and Stoker et al. (44) unless otherwise
stated.
b + and ts indicate absence and presence of temperature sensitivity,
respectively.
C Some residual growth is seen at 41°C (44).
d Stoker, unpublished data.
' Kellie et al., in press.
f Although total levels of complex are unchanged, the protein may exhibit
other defects in complex stability (see text).
8 Localization data from both cell fractionation and immunofluorescence of
pp6l0J-vrC (see text).
(nonconditionally) in a manner similar to LA29 at 41°C.
These mutants are kinase defective and predominantly cyto-
solic, and there is a low level of association with the complex
proteins. The mutation in LA29 lies in the region affected in
these site-directed variants, suggesting that both are defec-
tive in a similar, possibly regulatory domain-of the protein.
We cannot yet say whether the temperature-dependent
kinase defect of LA29 results from, is causative in, or is
unrelated to the transport defect. Given that genetic analysis
indicates a single mutation towards the 3' end of this v-src
gene, it is noteworthy that this mutant suffers from a number
of processing and functional defects, suggesting that the
lesion has pleiotropic effects on a structural or temporal
basis.
tsLA32. The LA32 mutant pp60-src shows no obvious
defect in complex formation or myristylation. The protein
also remains membrane localized to a significant degree at
nonpermissive temperature; in addition, we know the pro-
tein remains localized within adhesion plaques at 41°C
(Kellie et al., in press). We have therefore ruled out several
causes of the transformation defect in LA32 and suggest that
the lesion in the protein disrupts its function at a late stage in
maturation subsequent to membrane binding. It is likely that
the protein is impaired in some specific interaction required
at or near the plasma membrane, disrupting either kinase
substrate specificity or a critical association with other
cellular structures necessary for the maintenance of the
transformed state. Of interest here are two recent reports by
Garber et al. (19) and Cross et al. (12) describing pp60v-src
proteins with deletions between amino acids 15 and 169. This
region is within the area to which the LA32 lesion has been
mapped, and indeed the deletion mutants affect pp6v-src
behavior in a similar way. The kinase functions are not
apparently affected directly, and full morphological transfor-
mation of CEF expressing the proteins does not occur (cf.
LA32 at 35°C). These mutants and our LA32 data together
strongly suggest a critical functional role for domains in the
N-terminal half of pp6O-src.
It has recently been reported that pp60vsrc may be able to
cause phosphorylation of phosphoinositide derivatives in the
cell, either directly or indirectly, thus influencing a cell
biochemical pathway of importance in cell growth control
(45). Given that we have eliminated several sources of the
lesion in LA32, we are at present analyzing the possibility
that the mutant is defective in this function.
Although CEF infected with LA32 at 41°C show increased
phosphotyrosine levels and retain some anchorage-
independent growth (44), there are no residual structural
features of transformation in these cells, nor is the hexose
uptake rate elevated (A. Stoker, unpublished data). Indeed,
even at permissive temperature, cells transformed by LA32
show a less dramatic loss of fibronectin matrix and redistri-
bution of actin and a-actinin than similar cells transformed
by wild-type or LA29 virus. This correlates with the some-
what fusiform morphology ofLA32 transformants (44), and it
is of interest that we have mapped the lesion in a fully
fusiform variant of RSV (td SF/L0104) to the amino-terminal
half of pp60v-src (17). Sequencing of the v-src genes of LA32
(work in progress) and the fusiform virus should reveal
whether the ts and fusiform phenotypes represent distinct
mutations or manifestations of the same lesion.
In conclusion, we have analyzed two ts mutants of
pp6Ov-src which have lesions in different domains of the
protein and which present defects in pp6Ov-src function
varying in both pattern and degree. The LA29 mutant is of
interest considering the pleiotropic nature of the defects
expressed in pp60v-src. The mutation in LA32, in an as yet
undefined domain of pp60v-src, abolishes almost all transfor-
mation parameters at 41°C but has little effect on detectable
facets of pp60v-src maturation and function, with the excep-
tion of the previously demonstrated reduction in phosphor-
ylation of pp60v-src itself (44). This latter finding is under
continuing investigation at present.
Further studies with such ts mutants and elucidation of the
defects present should be of considerable value in advancing
our understanding of the mechanism of pp60v-srcmediated
cell transformation.
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